Population health impact was included by every firm as a source of motivation, either in the interview or in publicly available documents. In this case, CSR work preceded business presence and provided feedback that informed business strategies for expansion into this market.
Commissions sterile lyophilisation plant. Launches a range of new products in the sterile category. Becomes country's largest producer of oral and sterile cephalosporin.
Is ranked among the top five producers of cephalosporin APIs. Commissions plant for manufacturing nutraceutials. Sets up an office in USA.
Sets up an office in Russia. Inaugurates new Corporate Office. Signs an exclusive pact with Apotex to market select sterile antibiotic dosage forms in USA. Joint venture with Bexel moves its novel anti-diabetic molecule BLX into human clinicals.
Joint venture with Bexel successfully completes Phase 1 b clinical trials on its lead anti-diabetic molecule BLX Signs an agreement with Par Pharmaceuticals to market oral cephalosporin formulations in US market. Enters into an agreement with Apotex Inc.
Joint venture with Bexel successfully completes Phase 2 a trials on its lead anti-diabetic molecule BLX Molecule receives patent clearance from US patent office. Enters into an agreement with Phoenix for key veterinary injectable product.
Medicinal chemistry labs are commissioned in the New Drug Discovery center. Signs deal with Biovitrum in drug discovery field. Enters into a licensing and distribution alliance with Actavis to market cephalosporin formulations in Europe.
Forays into the Canadian generic formulations market. Enters into a marketing arrangement with a leading distribution house for oral cephalosporin and non-cephalosporin products. Completes the sterile carbapenem API facility in Aurangabad.
Completes the sterile carbapenem dosage form facility at Irungattukottai, Chennai. Diakrona US-based drug discovery and development company, which has an exclusive license agreement with Merck for the compound.
Enters into a research collaboration and license agreement with Merck to discover, develop and commercialise molecules essential for the treatment of bacterial and fungal infections. Orchid inks business transaction agreement with Hospira to transfer the generic injectables formulations dosage form pharmaceutical business for USD million.
Collaborates with Alvogen to license and market its eight oral non-antibiotic generic formulations. Acquires US-based marketing company Karalex Pharma, to strengthen its presence in the front-end US market and to reach its generic products to the US customers directly. Orchid received milestone payment from Merck on advancement of their research initiative to discover, develop and commercialize molecules essential for the treatment of bacterial and fungal infections.Kristine Allen, Co-Founder and President, Act Now Foundation’s Alzheimer’s Resource Center of New Jersey; Co-Chair & Member of Board of Directors, Community Networking Association of New Jersey Breakout Session: Improving Non-Profit Capacity Through Innovative Networking Toward Partnerships Ms.
Allen is the Co-Founder and President of Act Now Foundation’s Alzheimer’s Resource Center of. BRUCE LINTON FOUNDER, CHAIRMAN and CO-CEO.
Mr. Linton is the founder of Canopy Growth Corporation (CGC) and co-founder of Tweed Marijuana Incorporated. Download the full company profile: L'Oréal Company Profile - SWOT Analysis Download the full company profile: Coca-Cola Company Profile - SWOT Analysis Download the full company profile: Procter & Gamble Company Profile - SWOT Analysis Euromonitor International's report on Pfizer Inc delivers a detailed strategic analysis of the company's business, examining its performance in the Consumer.
Orchid Pharma is a vertically integrated pharmaceutical company spanning the entire pharmaceutical value chain from discovery to delivery with established credentials in .
May 14, · It's ten years into companies' efforts to engage in corporate social responsibility (CSR) and the returns for business still aren’t good enough. On the one hand, CSR . In an all-day Jury meeting held in Berlin on 20 September at Quadriga Forum, the shortlisted candidates will pitch their projects/campaigns to the heartoftexashop.com short presentation is an integral part of the application process and is, therefore, a prerequisite for winning the Digital Communication Awards.